Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer

The Journal of Urology
Stephen J FreedlandSEARCH Database Study Group

Abstract

Men newly diagnosed with prostate cancer are faced with multiple treatment options. Understanding these options and their associated side effects, and making a decision often requires time, resulting in a delay before receiving treatment. This is particularly pertinent in men with low risk disease who may be considered candidates for watchful waiting and, thus, may not experience strong pressure to undergo treatment promptly. Whether delays and especially prolonged delays, eg greater than 180 days, before RP negatively impact the disease outcome is unclear. We examined the association between time from diagnosis to surgery, and pathological features of the RP specimen and risk of biochemical progression in 895 men with low risk prostate cancer (prostate specific antigen less than 10 ng/ml and biopsy Gleason sum 6 or less) treated with RP between 1988 and 2004 in the Shared-Equal Access Regional Cancer Hospital Database using logistic regression and Cox proportional hazards, respectively. Time from biopsy to surgery was not significantly related to high grade disease in the RP specimen, positive surgical margins or extraprostatic extension (all p-trend >0.05). After adjustment for multiple clinical covariates a longer time from ...Continue Reading

References

May 11, 1999·JAMA : the Journal of the American Medical Association·C R PoundP C Walsh
Feb 8, 2002·The Journal of Urology·H Ballentine CarterJonathan I Epstein
Oct 19, 2002·Urology·Stephen J FreedlandUNKNOWN Shared Equal Access Regional Cancer Hospital Database Study Group
May 31, 2003·Scandinavian Journal of Urology and Nephrology·Ali KhatamiJonas Hugosson
Sep 18, 2003·Journal of the National Cancer Institute·Anthony V D'AmicoMing-Hui Chen
Nov 16, 2004·The Journal of Urology·Masood A KhanAlan W Partin
Jul 28, 2005·JAMA : the Journal of the American Medical Association·Stephen J FreedlandAlan W Partin

❮ Previous
Next ❯

Citations

Feb 15, 2008·Der Urologe. Ausg. A·M GraefenH Huland
Apr 2, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lionel L BañezStephen J Freedland
Aug 21, 2013·BMC Health Services Research·Melissa A SimonAlfred W Rademaker
Aug 17, 2010·Clinical Interventions in Aging·Jaspreet SinghLeonard G Gomella
Aug 10, 2010·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Christiaan StevensD Andrew Loblaw
Jun 25, 2014·Der Urologe. Ausg. A·K LelligC Stief
Sep 21, 2011·Radiology·Caroline M A HoeksJurgen J Fütterer
May 2, 2012·Journal of Cancer Research and Clinical Oncology·Kwang Hyun KimChoung-Soo Kim
Feb 3, 2016·Der Urologe. Ausg. A·Annika Herlemann, Christian G Stief
Mar 5, 2013·European Urology·Roderick C N van den BerghHenk G van der Poel
Feb 9, 2012·BJU International·Giles O Hellawell, Jeetesh Bhardwa
Jun 8, 2012·The Journal of Sexual Medicine·Maxine SunPierre I Karakiewicz
Nov 19, 2011·BJU International·Ruslan KoretsJames M McKiernan
Jan 13, 2010·Cancer·Roderick C N van den BerghUNKNOWN Swedish and Dutch sections of the European Randomized Study of Screening for Prostate Cancer
Apr 20, 2016·Journal of Comparative Effectiveness Research·James R Broughman, Ronald C Chen
Apr 3, 2008·Mayo Clinic Proceedings·Kenneth G NeppleTerry L Wahls
Apr 19, 2011·The Journal of Urology·Daniel O'BrienWilliam J Catalona
May 12, 2012·Urologic Oncology·Michael R AbernChristopher L Coogan
Jun 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Rui FengHui-Ping Li
Jun 15, 2007·Nature Clinical Practice. Urology·Stacy Loeb, William J Catalona
Jan 25, 2019·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Mary E WestermanRobert Jeffrey Karnes
May 31, 2012·MMW Fortschritte der Medizin·Katja ZilinbergChristian G Stief
Mar 20, 2018·World Journal of Urology·Mariana Andozia MoriniEliney Ferreira Faria
Nov 26, 2020·JAMA Oncology·Michael S LeapmanXiaomei Ma
Jan 12, 2007·Annales D'urologie·A DescazeaudM Peyromaure

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.